Advanced chronic kidney disease in non-valvular atrial fibrillation: Extending the utility of R2CHADS2 to patients with advanced renal failure

Clinical Kidney Journal

Volumn 8, Issue 2, 2015, Pages 226-231

  Bautista, Josef ^a   Bella, Archie ^a   Chaudhari, Ashok ^a   Pekler, Gerald ^a   Sapra, Katherine J ^b   Carbajal, Roger ^a   Baumstein, Donald ^a  

^a METROPOLITAN HOSPITAL CENTER   (United States)

^b Department of Medicine   (United States)

Author keywords

Anticoagulation; Atrial fibrillation; CKD; Clinical prediction rule; Stroke

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHA2DS2VASC SCORE; CHADS SCORE; CHADS2 SCORE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; R2CHADS2 SCORE; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

EID: 84934913350     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfv006     Document Type: Article

References (14)

1. Coppens M, Eikelboom JW, Hart RG et al. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J 2013; 34: 170-176
2. Rockson SG, Albers GW. Comparing the guidelines: Anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. J Am Coll Cardiol 2004; 43: 929-935
3. Go AS, Fang MC, Udaltsova N et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Circulation 2009; 119: 1363-1369
4. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-1065
5. Baber U, Howard VJ, Halperin JL et al. Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Circ Arrhythm Electrophysiol 2011; 4: 26-32
6. Olesen JB, Lip GY, Kamper AL et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012; 367: 625-635
7. Piccini JP, Stevens SR, Chang Y et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: Validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation 2013; 127: 224-232
8. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
9. Wattanakit K, Cushman M, Stehman-breen C et al. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol 2008; 19: 135-140
10. Wang CC, Lin CL, Wang GJ et al. Atrial fibrillation associated with increased risk of venous thromboembolism. A Population- Based Cohort Study. Thromb Haemost 2015; 113: 185-192
11. Marinigh R, Lane DA, Lip GY. Severe renal impairment and stroke prevention in atrial fibrillation: Implications for thromboprophylaxis and bleeding risk. J Am Coll Cardiol 2011; 57: 1339-1348
12. Vázquez E, Sánchez-perales C, Borrego F et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 2000; 140: 886-890
13. Roldán V, Marín F, Manzano-fernandez S et al. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost 2013; 109: 956-960
14. Kornej J, Hindricks G, Kosiuk J et al. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol 2013; 6: 868-874